You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 632 Clinical update from a phase 1, first-in-human, open-label single agent study of SUPLEXA therapeutic cells in patients with metastatic solid tumours and haematologic malignancies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
632 Clinical update from a phase 1, first-in-human, open-label single agent study of SUPLEXA therapeutic cells in patients with metastatic solid tumours and haematologic malignancies
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

AbstractFullPdf
Nov 2022446030
Dec 20228607
Jan 202311404
Feb 20239006
Mar 20239208
Apr 2023224029
May 20234401
Jun 20234804
Jul 20233206
Aug 20234304
Sep 20232603
Oct 20235806
Nov 202310302
Dec 20237406
Jan 202426031
Feb 20242804
Mar 20243406
Total15680157